MedPath

The Effects of Chiropractic in Adults With Colon Cancer

Not Applicable
Withdrawn
Conditions
Colon Cancer Stage III
Colon Cancer Stage IV
Interventions
Procedure: HVLA cervical chiropractic adjustments
Registration Number
NCT05310565
Lead Sponsor
Life University
Brief Summary

The main objectives of this single-arm pilot trial are to investigate the feasibility of our protocol in terms of 1) recruitment, 2) adherence, 3) tolerability, 4) acceptability and 5) retention. We aim to recruit 20 participants with advanced colon cancer (stage 3-4) who will have assessments of their autonomic nervous system function, carcinoembryonic antigen (CEA) levels, and patient-reported outcomes. Thereafter, patients will be directed to a nearby field clinic to receive twice-weekly cervical assessments \& high-velocity, low-amplitude (HVLA) cervical adjustments for a period of 6 weeks. Re-assessments will be performed following 2 weeks and 6 weeks of chiropractic care.

Detailed Description

After providing informed consent, individuals will undergo 6 weeks of chiropractic care. Throughout these 6 weeks there will be three assessments (Day 1, Week 2, and Week 6) that each include the following:

1. Isometric hand grip

2. Postural challenge

3. Patient-reported outcome surveys

4. Off-site blood draw for CEA level testing (only Day 0 and Week 6)

Each assessment will consist of the following recordings:

1. Electrodermal activity \[EDA\]

2. Impedance cardiography \[ICG\]

3. Electrocardiogram \[ECG\]

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Males & females 18 years of age or older
  • Able to provide informed consent
  • Diagnosed with stage 3 or stage 4 colon cancer and currently receiving standard of care with a medical doctor.
Exclusion Criteria
  • Individuals with a known disorder resulting in syncope/fainting during postural changes (e.g., POTS, orthostatic hypotension)
  • Cancer has metastasized to the cervical spine
  • Individuals who have had a serious injury or surgery to the head, torso, lower body within the past 6 months.
  • Individuals with evidence or medical history of clinically significant psychiatric disorder like anti-social disorder, schizophrenia, or borderline personality disorder that is uncontrolled or untreated.
  • Individuals who currently have pending health related legal litigation.
  • Individuals with a known heart condition (e.g., arrhythmia) that could result in an aberrant electrocardiogram.
  • Individuals with a pacemaker
  • Individuals who are on short benzodiazepines which include midazolam & triazolam
  • Individuals with conditions that could result in neck instability such as rheumatoid arthritis.
  • Individuals who do not present with a subluxation in the upper cervical region (C1/C2) at any point during the 6 weeks of chiropractic care.
  • Individuals with a condition that may cause weak or brittle bones such as osteoporosis
  • Since x-rays may be requested for care, participants who are pregnant will be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ChiropracticHVLA cervical chiropractic adjustmentsCervical chiropractic care
Primary Outcome Measures
NameTimeMethod
Recruitment rateUpon reaching target number of completed participant trials

Length of time needed to recruit target number of participants

Patient adherence rateUpon reaching target number of completed participant trials

Proportion of participants able to adhere to the testing \& treatment protocol/schedule

Patient RetentionUpon reaching target number of completed participant trials

Proportion of enrolled participants who complete the full trial

Patient tolerability rateUpon reaching target number of completed participant trials

Proportion of participants able to perform all aspects of the testing regimen

Acceptability of treatment regimen to participantsWeek 6

8-item Theoretical Framework of Acceptability questionnaire

Secondary Outcome Measures
NameTimeMethod
Impedance cardiogram (ICG) initial systolic time interval (ISTI)Week 6

2 sensors on chest and 2 sensors on back

Electrodermal activity (EDA) skin conductance level (SCL)Week 6

2 sensors on first and second digits of non-dominant hand

ECG interbeat intervalWeek 6

3 sensors on torso

Carcinoembryonic antigen (CEA) levelsWeek 6

Off-site blood draw and lab testing

Electrodermal activity (EDA) power spectral density (PSD)Week 6

2 sensors on first and second digits of non-dominant hand

ECG respiratory sinus arrhythmia (RSA)Week 6

3 sensors on torso

Patient-reported outcomesWeek 6

5 questionnaires: EORTC QLQ-C30, COMPASS-31, PROMIS-29, PROMIS-Cog, Perceived Stress Scale

Electrodermal activity (EDA) non-specific skin conductance responses (SCR)Week 6

2 sensors on first and second digits of non-dominant hand

Impedance cardiogram (ICG) pre-ejection period (PEP)Week 6

2 sensors on chest and 2 sensors on back

ECG de-trended fluctuation analysisWeek 6

3 sensors on torso

Trial Locations

Locations (1)

Dr. Sid E. Williams Center for Chiropractic Research

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath